News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Music

Glenn Frey eyes Eagles musical

glennfrey

The guitarist is contemplating developing a musical based on songs of the Eagles.

in Music

Roger Daltrey predicts this is the last Who tour

rogerdaltrey

Roger Daltrey says he used to try to sing like it's the first time, but now he sings for what might be the last time.

in Music

Andy Summers: ‘The Police will always have a special bond’

andysummers

Industry insiders claimed the trio's most recent reunion fell apart amid backstage squabbles, but the guitarist says it's just not true.